Cargando…
Statin Therapy Is Associated With Lower Total but Not Bioavailable or Free Testosterone in Men With Type 2 Diabetes
OBJECTIVE: There is a high prevalence of hypogonadism in men with type 2 diabetes. This will lead to an increase in assessments of hypogonadism. Statins could potentially decrease testosterone levels by reducing the availability of cholesterol for androgen synthesis. We compared testosterone levels...
Autores principales: | Stanworth, Roger D., Kapoor, Dheeraj, Channer, Kevin S., Jones, T. Hugh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660443/ https://www.ncbi.nlm.nih.gov/pubmed/19114614 http://dx.doi.org/10.2337/dc08-1183 |
Ejemplares similares
-
Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Jones, T. Hugh, et al.
Publicado: (2011) -
Correlative studies on vitamin D and total, free bioavailable testosterone levels in young, healthy men
por: Książek, Anna, et al.
Publicado: (2021) -
Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone–binding globulin, and hypertension
por: Yang, Qingtao, et al.
Publicado: (2019) -
Testosterone for the aging male; current evidence and recommended practice
por: Stanworth, Roger D, et al.
Publicado: (2008) -
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
por: Jones, T. Hugh, et al.
Publicado: (2011)